Immunovant (IMVT)
Nasdaq • IMVT • US45258J1025
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 19.8% of free float sold short, 12.9 days to cover, cost to borrow 0.37%. Sign up for live short interest data.
Market Cap
7.39b USD | # 1989 in US
Volume
1.44m shares | 50.52m USD
Shares Outstanding
206.55m
Free Float Shares
44.43% | 91.77m
